Presentation TCT 2025 TCT 1519: Jailed, but Unharmed: Navigating Bi-Caval TricValve Implantation in Tricuspid Regurgitation With Multiple Pre-Existing Leads: A Complex Case From the TRICAV I US Early Feasibility Study Presenter: Brian K. Whisenant October 28, 2025
Presentation NY Valves 2025 The Impact of Preprocedural Optimization: Maximizing TTVI Outcomes Presenter: Brian K. Whisenant June 26, 2025
Presentation NY Valves 2025 Not if the Invasive Gradients Look Fine Presenter: Brian K. Whisenant June 26, 2025
Presentation TCT 2024 Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned? Presenter: Brian Whisenant October 30, 2024
News Conference News NY Valves 2024 T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies Todd Neale June 07, 2024
Presentation NY Valves 2024 Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications? Presenter: Brian K. Whisenant June 07, 2024
Presentation NY Valves 2024 Topline Results from the TRILUMINATE Transcatheter Tricuspid Edge-to-Edge Repair Trial Presenter: Brian K. Whisenant June 07, 2024
Presentation NY Valves 2024 T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial Presenter: Brian K. Whisenant June 06, 2024
News Conference News TCT 2023 MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4 Yael L. Maxwell November 02, 2023
Presentation TVT 2023 LAAC Safety: Current Data and Practices Presenter: Brian Whisenant June 09, 2023
Presentation TVT 2023 Patients With AS and Atrial Fibrillation: Updates on the WATCH-TAVR Trial Presenter: Brian Whisenant June 08, 2023
Presentation THT 2023 MitraClip for Secondary Mitral Regurgitation with LVEF < 20% Presenter: Brian Whisenant March 20, 2023
Presentation TCT 2022 The Argument for a TEER Trial in the FMR Space – CLASP IIF Presenter: Brian Whisenant September 18, 2022
Presentation TCT 2022 Valve in Bioprosthetic Mitral Failure: Technical Considerations, Outcomes, and Complications Presenter: Brian Whisenant September 17, 2022